Group A and Group C Meningococcal Conjugate Vaccine (CRM197) Menphecia®

Group A and Group C Meningococcal Conjugate Vaccine (CRM197) Menphecia®
Product Description

  • China's first bivalent meningococcal conjugate vaccine using CRM197 vector
  • Provides protection against two serotypes (group A and group C)
  • Safer and better

Read more Show less

CanSino Biologics Inc.

  • Country/Region:
    China
  • On CPHI since:
    2024
  • Certificates:
    1
  • Employees:
    1000 - 4999
Company types
Biopharmaceutical company
Primary activities
Biopharmaceutical
Technology
View company profile
Categories
more categories Show less
Specifications
  • Details
    0.5 mL/vial after reconstituted, single dose containing lyophilized group A and C meningococcal conjugate vaccine component, reconstitute before use.
  • Model
    Solution for Intramuscular Injection
  • Supplied from
    China
More specifications Fewer specifications
Sales Markets
Show more Show less

CanSino Biologics Inc.

  • Country/Region:
    China
  • On CPHI since:
    2024
  • Certificates:
    1
  • Employees:
    1000 - 4999
Company types
Biopharmaceutical company
Primary activities
Biopharmaceutical
Technology
View company profile

More Products from CanSino Biologics Inc. (2)

  • Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) Menhycia®

    Product Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) Menhycia®

    More Serogroup: Men ACWY
    Long lasting: immunization memory, High affinity IgG, Mucosal immunity.
    Strong Evidence: A 10-year evidence of MenACWY CRM Menhycia® evidence.
    Saftey: A 10-year evidence of Men ACWY CRM Menhycia® evidence Safety of CRM 197

    ...
  • 13-valent Pneumococcal Polysaccharide Conjugate Vaccine (CRM197/TT)

    Product 13-valent Pneumococcal Polysaccharide Conjugate Vaccine (CRM197/TT)

    Active immunization for the prevention of invasive diseases (including bacteremic pneumonia, meningitis, sepsis, bacteremia, etc.) caused by Streptococcus pneumoniae serotypes of 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F in infants and children from 2 months (minimum 6 weeks) to 5 years of age.